Pulmonary hypertension: diagnostic and therapeutic challenges

References

• SimonneauGGatzoulisMAAdatiaIUpdated clinical classification of pulmonary hypertensionJ Am Coll Cardiol20136225_SD34D4124355639
   PubMed Web of Science ®Google Scholar
• MozaffarianDBenjaminEJGoASAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2015 update: a report from the American Heart AssociationCirculation20151314e29e32225520374
   PubMed Web of Science ®Google Scholar
• TuderRMArcherSLDorfmüllerPRelevant issues in the pathology and pathobiology of pulmonary hypertensionJ Am Coll Cardiol20136225D4D1224355640
   PubMed Web of Science ®Google Scholar
• HumbertMMorrellNWArcherSLCellular and molecular pathobiology of pulmonary arterial hypertensionJ Am Coll Cardiol20044312 supplS13S24
   PubMed Web of Science ®Google Scholar
• GalièNHoeperMMHumbertMTask Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC)European Respiratory Society (ERS)International Society of Heart and Lung Transplantation (ISHLT)Guidelines for the diagnosis and treatment of pulmonary hypertensionEur Respir J20093461219126319749199
   PubMed Web of Science ®Google Scholar
• FisherMRForfiaPRChameraEAccuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertensionAm J Respir Crit Care Med200917961562119164700
   PubMed Web of Science ®Google Scholar
• JandaSShahidiNGinKSwistonJDiagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysisHeart20119761262221357375
   PubMed Web of Science ®Google Scholar
• RaymondRJHinderliterALWillisPWEchocardiographic predictors of adverse outcomes in primary pulmonary hypertensionJ Am Coll Cardiol20023971214121911923049
   PubMed Web of Science ®Google Scholar
• SaulerMFaresWHTrowTKStandard nonspecific therapies in the management of pulmonary arterial hypertensionClin Chest Med201334479981024267305
   PubMed Web of Science ®Google Scholar
• MaronBAWaxmanABOpotowskyAREffectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)Am J Cardiol2013112572072523751938
   PubMed Web of Science ®Google Scholar
• MaronBALeopoldJAThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Pulm Circ2014420021025006439
   PubMed Web of Science ®Google Scholar
• McLaughlinVVArcherSLBadeschDBAmerican College of Cardiology Foundation Task Force on Expert Consensus DocumentsAmerican Heart AssociationAmerican College of Chest PhysiciansAmerican Thoracic Society, IncPulmonary Hypertension AssociationACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension AssociationJ Am Coll Cardiol200953171573161919389575
   PubMed Web of Science ®Google Scholar
• RichSKaufmannELevyPSThe effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertensionN Engl J Med1992327276811603139
   PubMed Web of Science ®Google Scholar
• FaresWHTrowTKTargeted approaches to the treatment of pulmonary hypertensionTher Adv Respir Dis2012614715922438264
   PubMed Web of Science ®Google Scholar
• RuanCHDixonRAWillersonJTRuanKHProstacyclin therapy for pulmonary arterial hypertensionTex Heart Inst J201037439139920844610
   PubMed Web of Science ®Google Scholar
• RubinLJMendozaJHoodMTreatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trialAnn Intern Med199011274854912107780
   PubMed Web of Science ®Google Scholar
• BarstRJRubinLJLongWAPrimary Pulmonary Hypertension Study GroupA comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionN Engl J Med199633452963018532025
   PubMed Web of Science ®Google Scholar
• BadeschDBTapsonVFMcGoonMDContinuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialAnn Intern Med200013242543410733441
   PubMed Web of Science ®Google Scholar
• BenzaRLTapsonVFGomberg-MaitlandMPomsABarstRJMcLaughlinVVOne-year experience with intravenous treprostinil for pulmonary arterial hypertensionJ Heart Lung Transplant201332988989623953817
   PubMed Web of Science ®Google Scholar
• JingZCParikhKPulidoTEfficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trialCirculation2013127562463323307827
   PubMed Web of Science ®Google Scholar
• KrishnanUTakatsukiSIvyDDEffectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in childrenAm J Cardiol2012110111704170922917554
   PubMed Web of Science ®Google Scholar
• FaresWHOrenitram…. not verifiedAm J Respir Crit Care Med2015191671371425767926
   PubMed Web of Science ®Google Scholar
• KholdaniCAFaresWHTrowTKMacitentan for the treatment of pulmonary arterial hypertensionVasc Health Risk Manag20141066567325473292
   PubMedGoogle Scholar
• BadeschDBFeldmanJKeoghAARIES-3 Study GroupARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertensionCardiovasc Ther2012302939921884013
   PubMed Web of Science ®Google Scholar
• GalieNOlschewskiHOudizRJAmbrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) GroupAmbrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2Circulation20081173010301918506008
   PubMed Web of Science ®Google Scholar
• PulidoTAdzerikhoIChannickRNSERAPHIN InvestigatorsMacitentan and morbidity and mortality in pulmonary arterial hypertensionN Engl J Med2013369980981823984728
   PubMed Web of Science ®Google Scholar
• FanYFZhangRJiangXThe phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertensionCardiovasc Res20139939540323650288
   PubMed Web of Science ®Google Scholar
• GalièNBrundageBHGhofraniHAPulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study GroupTadalafil therapy for pulmonary arterial hypertensionCirculation2009119222894290319470885
   PubMed Web of Science ®Google Scholar
• GhofraniHAGalièNGrimmingerFPATENT-1 Study GroupRiociguat for the treatment of pulmonary arterial hypertensionN Engl J Med2013369433034023883378
   PubMed Web of Science ®Google Scholar
• BenzaRLGomberg-MaitlandMMillerDPThe REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertensionChest201214135436221680644
   PubMed Web of Science ®Google Scholar
• GalièNCorrisPAFrostAUpdated treatment algorithm of pulmonary arterial hypertensionJ Am Coll Cardiol20136225 supplD60D7224355643
   PubMed Web of Science ®Google Scholar
• RubinLBarberaJFrostAUpfront combination therapy with ambrisentan and tadalafiliin treatment naive patients with Pulmonary Arterial Hypertension (PAH): subgroup analyses by Functional Class (FC), etiology, and region from the AMBITION StudyChest2014146339A339A 4_MeetingAbstracts24722914
   PubMedGoogle Scholar
• RaghuGBehrJBrownKKARTEMIS-IPF InvestigatorsTreatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialAnn Intern Med201315864164923648946
   PubMed Web of Science ®Google Scholar
• TaichmanDBOrnelasJChungLPharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel reportChest201414644947524937180
   PubMed Web of Science ®Google Scholar
• DoyleRLMcCroryDChannickRNSimonneauGConteJSurgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest200412663S71S15249495
   PubMed Web of Science ®Google Scholar
• PeacockAJMurphyNFMcMurrayJJVCaballeroLStewartSAn epidemiological study of pulmonary arterial hypertensionEur Respir J200730110410917360728
   PubMed Web of Science ®Google Scholar
• HumbertMSitbonOChaouatAPulmonary arterial hypertension in France: results from a national registryAm J Respir Crit Care Med20061731023103016456139
   PubMed Web of Science ®Google Scholar
• CoganJDPauciuloMWBatchmanAPHigh frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertensionAm J Respir Crit Care Med200617459059816728714
   PubMed Web of Science ®Google Scholar
• ChidaAShintaniMNakayamaTMissense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertensionCirc J2012761501150822374147
   PubMed Web of Science ®Google Scholar
• ThomsonJRMachadoRDPauciuloMWSporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJ Med Genet2000371074174511015450
   PubMed Web of Science ®Google Scholar
• AustinEDLoydJEPhillipsJAHeritable pulmonary arterial hypertensionGeneReviews(R)Seattle WAUniversity of Washington, Seattle2015
   Google Scholar
• EddahibiSAdnotSAnorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesisRespir Res20023911806844
   PubMed Web of Science ®Google Scholar
• MontaniDSeferianASavaleLSimonneauGHumbertMDrug-induced pulmonary arterial hypertension: a recent outbreakEur Respir Rev20132224425023997051
   PubMedGoogle Scholar
• GoldbergAPulmonary arterial hypertension in connective tissue diseasesCardiol Rev201018858820160534
   PubMed Web of Science ®Google Scholar
• KamelSROmarGMDarwishAFAsklanyHTEllabbanASAsymptomatic pulmonary hypertension in systemic lupus erythematosusClin Med Insights Arthritis Musculoskelet Disord20114778622084605
   PubMedGoogle Scholar
• BadeschDBRaskobGEElliottCGPulmonary arterial hypertension: baseline characteristics from the REVEAL registryChest201013737638719837821
   PubMed Web of Science ®Google Scholar
• McGoonMDMillerDPREVEAL: a contemporary US pulmonary arterial hypertension registryEuropean Respiratory Review20122112381822379169
   PubMedGoogle Scholar
• ChungLLiuJParsonsLCharacterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotypeChest20101381383139420507945
   PubMed Web of Science ®Google Scholar
• SteenVMedsgerTAJrPredictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis Rheum200348251652212571862
   PubMed Web of Science ®Google Scholar
• XiaYKTuSHHuYHPulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese populationRheumatol Int20133351211121722983159
   PubMed Web of Science ®Google Scholar
• DhalaAPulmonary arterial hypertension in systemic lupus erythematosus: current status and future directionClin Dev Immunol2012201285494122489252
   PubMedGoogle Scholar
• BarnettCFHsuePYHuman immunodeficiency virus-associated pulmonary arterial hypertensionClin Chest Med201334228329223702177
   PubMed Web of Science ®Google Scholar
• SelbyVNScherzerRBarnettCFDoppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patientsAIDS201226151967196922781217
   PubMed Web of Science ®Google Scholar
• PuglieseAIsnardiDSainiAScarabelliTRaddinoRTorreDImpact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvementJ Infect200040328228410908024
   PubMed Web of Science ®Google Scholar
• DeganoBGuillaumeMSavaleLHIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic eraAIDS2010241677519770696
   PubMed Web of Science ®Google Scholar
• Gary-BoboGHoussainiAAmsellemVEffects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in ratsCirculation2010122191937194720974998
   PubMed Web of Science ®Google Scholar
• ThompsonMAAbergJAHoyJFAntiretroviral treatment of adult HIV infection: 2012 Recommendations of the International Antiviral Society-USA panelJAMA2012308438740222820792
   PubMed Web of Science ®Google Scholar
• IeongMHFarberHWNoninfectious pulmonary complications of HIVClin Pulm Med2006133194202
   Google Scholar
• SchumacherYOZdebikAHuonkerMKreiselWSildenafil in HIV-related pulmonary hypertensin [3]AIDS200115131747174811546958
   PubMed Web of Science ®Google Scholar
• AguilarRVFarberHWEpoprostenol (Prostacyclin) therapy in HIV-associated pulmonary hypertensionAm J Respir Crit Care Med200016251846185011069824
   PubMed Web of Science ®Google Scholar
• MyersPOTissotCBeghettiMAssessment of operability of patients with pulmonary arterial hypertension associated with congenital heart diseaseCirc J20147841124225339
   PubMed Web of Science ®Google Scholar
• BergerRMBeghettiMHumplTClinical features of paediatric pulmonary hypertension: a registry studyLancet2012379981553754622240409
   PubMed Web of Science ®Google Scholar
• GalieNManesAPalazziniMManagement of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger’s syndromeDrugs2008681049106618484798
   PubMed Web of Science ®Google Scholar
• McDonnellPJToyePAHutchinsGMPrimary pulmonary hypertension and cirrhosis: are they related?Am Rev Respir Dis198312744374416838050
   PubMedGoogle Scholar
• HoeperMMKrowkaMJStrassburgCPPortopulmonary hypertension and hepatopulmonary syndromeLancet20043631461146815121411
   PubMed Web of Science ®Google Scholar
• FusterVSteelePMEdwardsWDGershBJMcGoonMDFryeRLPrimary pulmonary hypertension: natural history and the importance of thrombosisCirculation19847045805876148159
   PubMed Web of Science ®Google Scholar
• KuoPCJohnsonLBPlotkinJSHowellCDBartlettSTRubinLJContinuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertensionTransplantation19976346046069047158
   PubMed Web of Science ®Google Scholar
• PlotkinJSKuoPCRubinLJSuccessful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertensionTransplantation19986544574599500616
   PubMed Web of Science ®Google Scholar
• GrahamBBBandeiraAPMorrellNWButrousGTuderRMSchistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspectiveChest201013720S29S20522577
   PubMed Web of Science ®Google Scholar
• GhioSGavazziACampanaCIndependent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failureJ Am Coll Cardiol20013718318811153735
   PubMed Web of Science ®Google Scholar
• VahanianABaumgartnerHBaxJGuidelines on the management of valvular heart diseaseEur Heart J200728223026817259184
   PubMed Web of Science ®Google Scholar
• RedfieldMMChenHHBorlaugBARELAX TrialEffect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialJAMA2013309121268127723478662
   PubMed Web of Science ®Google Scholar
• SeegerWAdirYBarberàJAPulmonary hypertension in chronic lung diseasesJ Am Coll Cardiol20136225, supplD109D11624355635
   PubMed Web of Science ®Google Scholar
• ScharfSMIqbalMKellerCCrinerGLeeSFesslerHEHemodynamic characterization of patients with severe emphysemaAm J Respir Crit Care Med2002166331432212153963
   PubMed Web of Science ®Google Scholar
• EddahibiSChaouatAMorrellNPolymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary diseaseCirculation2003108151839184414530202
   PubMed Web of Science ®Google Scholar
• ChaouatABugnetASKadaouiNSevere pulmonary hypertension and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200517218919415831842
   PubMed Web of Science ®Google Scholar
• Oswald-MammosserMWeitzenblumEQuoixEPrognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureChest19951075119311987750305
   PubMed Web of Science ®Google Scholar
• LettieriCJNathanSDBarnettSDAhmadSShorrAFPrevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosisChest200612974675216537877
   PubMed Web of Science ®Google Scholar
• HamadaKNagaiSTanakaSSignificance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosisChest2007131365065617317730
   PubMed Web of Science ®Google Scholar
• KimuraMTaniguchiHKondohYPulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosisRespiration201385645646323257350
   PubMed Web of Science ®Google Scholar
• NathanSDShlobinOAAhmadSSerial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosisRespiration200876328829418216461
   PubMed Web of Science ®Google Scholar
• KholdaniCFaresWHMohseninVPulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiologyPulm Circ20155222022726064448
   PubMed Web of Science ®Google Scholar
• CorteTJWortSJGatzoulisMAElevated brain natriuretic peptide predicts mortality in interstitial lung diseaseEur Respir J201036481982520223915
   PubMed Web of Science ®Google Scholar
• CollardHRAnstromKJSchwarzMIZismanDASildenafil improves walk distance in idiopathic pulmonary fibrosisChest2007131389789917356110
   PubMed Web of Science ®Google Scholar
• ZismanDASchwarzMAnstromKJCollardHRFlahertyKRHunninghakeGWA controlled trial of sildenafil in advanced idiopathic pulmonary fibrosisN Engl J Med2010363762062820484178
   PubMed Web of Science ®Google Scholar
• BlancoIGimenoEMunozPAHemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertensionAm J Respir Crit Care Med2010181327027819875684
   PubMed Web of Science ®Google Scholar
• RaghuGMillion-RousseauRMorgantiAPerchenetLBehrJMacitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trialEur Respir J2013421622163223682110
   PubMed Web of Science ®Google Scholar
• PengoVLensingAWPrinsMHThromboembolic Pulmonary Hypertension Study GroupIncidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismN Engl J Med200435022572264 Massachusetts Medical Society15163775
   PubMed Web of Science ®Google Scholar
• TunariuNGibbsSJWinZVentilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertensionJ Nucl Med20074868068417475953
   PubMed Web of Science ®Google Scholar
• MayerEJenkinsDLindnerJSurgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registryJ Thorac Cardiovasc Surg201114170271021335128
   PubMed Web of Science ®Google Scholar
• FreedDHThomsonBMBermanMSurvival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertensionJ Thorac Cardiovasc Surg2011141383387 United States: A 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc.20471039
   PubMed Web of Science ®Google Scholar
• BondermanDSkoro-SajerNJakowitschJPredictors of outcome in chronic thromboembolic pulmonary hypertensionCirculation20071152153215817420352
   PubMed Web of Science ®Google Scholar
• JaïsXD’ArminiAMJansaPBosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study GroupBosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan effects in iNopErable forms of chronIc thromboembolic pulmonary hypertension), a randomized, placebo-controlled trialJ Am Coll Cardiol2008522127213419095129
   PubMed Web of Science ®Google Scholar
• GhofraniH-AD’ArminiAMGrimmingerFRiociguat for the treatment of chronic thromboembolic pulmonary hypertensionN Engl J Med2013369431932923883377
   PubMed Web of Science ®Google Scholar
• HoeperMMBogaardHJCondliffeRDefinitions and diagnosis of pulmonary hypertensionJ Am Coll Cardiol20136225_SD42D5024355641
   PubMed Web of Science ®Google Scholar